Auswahl der wissenschaftlichen Literatur zum Thema „Infections à Acinetobacter – Chimiothérapie“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Infections à Acinetobacter – Chimiothérapie" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Infections à Acinetobacter – Chimiothérapie"
Wilson, Brigid M., Federico Perez, Qing Pan, Yunyun Jiang, Scott R. Evans und Robert A. Bonomo. „Acinetobacter Infections“. Clinical Infectious Diseases 71, Nr. 5 (17.11.2019): 1357–58. http://dx.doi.org/10.1093/cid/ciz1099.
Der volle Inhalt der QuelleSnoeck, R., und E. De Clercq. „La chimiothérapie des infections a cytomégalovirus“. Médecine et Maladies Infectieuses 18 (März 1988): 79–84. http://dx.doi.org/10.1016/s0399-077x(88)80102-1.
Der volle Inhalt der QuelleÖzgür, Özlem, und Necmi Aksaray. „Acinetobacter Infections and Treatment“. Journal of Pediatric Infection 8, Nr. 1 (17.03.2014): 28–32. http://dx.doi.org/10.5152/ced.2013.38.
Der volle Inhalt der QuelleJoly-Guillou, M. L. „Acinetobacter et infections nosocomiales“. Revue Française des Laboratoires 2002, Nr. 345 (September 2002): 14. http://dx.doi.org/10.1016/s0338-9898(02)80247-5.
Der volle Inhalt der QuelleFalagas, M. E., E. A. Karveli, I. Kelesidis und T. Kelesidis. „Community-acquired Acinetobacter infections“. European Journal of Clinical Microbiology & Infectious Diseases 26, Nr. 12 (16.08.2007): 857–68. http://dx.doi.org/10.1007/s10096-007-0365-6.
Der volle Inhalt der QuelleGarnacho-Montero, José, und Jean-François Timsit. „Managing Acinetobacter baumannii infections“. Current Opinion in Infectious Diseases 32, Nr. 1 (Februar 2019): 69–76. http://dx.doi.org/10.1097/qco.0000000000000518.
Der volle Inhalt der QuelleBergogne-Bérézin, E. „Treatment of Acinetobacter infections“. Expert Opinion on Investigational Drugs 6, Nr. 2 (Februar 1997): 119–27. http://dx.doi.org/10.1517/13543784.6.2.119.
Der volle Inhalt der QuelleMiah, Md Ruhul Amin. „Acinetobacter baumannii Hospital Acquired Infections.“ Bangladesh Journal of Medical Microbiology 13, Nr. 1 (10.01.2019): 1–3. http://dx.doi.org/10.3329/bjmm.v13i1.51778.
Der volle Inhalt der QuelleFleming, Irma D., Monika A. Krezalek, Natalia Belogortseva, Alexander Zaborin, Jennifer Defazio, Laxmipradha Chandrasekar, Luis A. Actis, Olga Zaborina und John C. Alverdy. „Modeling Acinetobacter baumannii wound infections“. Journal of Trauma and Acute Care Surgery 82, Nr. 3 (März 2017): 557–65. http://dx.doi.org/10.1097/ta.0000000000001338.
Der volle Inhalt der QuelleLevin, Anna S. „Treatment of Acinetobacter spp. infections“. Expert Opinion on Pharmacotherapy 4, Nr. 8 (August 2003): 1289–96. http://dx.doi.org/10.1517/14656566.4.8.1289.
Der volle Inhalt der QuelleDissertationen zum Thema "Infections à Acinetobacter – Chimiothérapie"
Antraygues, Kévin. „Conception, synthèse et évaluation biologique de nouveaux ansamacrolides dans le traitement d'infections bactériennes“. Electronic Thesis or Diss., Université de Lille (2022-....), 2022. http://www.theses.fr/2022ULILS027.
Der volle Inhalt der QuelleAntimicrobial resistance is a major public health issue nowadays and this will be even more true in the coming decades. Among the bacteria involved in this alarming phenomenon, Acinetobacter baumannii and Mycobacterium abscessus are both resistant to many antibiotics currently available on the market. Research and development of new antibiotics is therefore necessary to fight these pathogens.Rifabutin, a semi-synthetic macrocyle of the rifamycin class, has recently shown interesting in vitro activities against A. baumannii and M. abscessus, which then translated into in vivo efficacy. Rifabutin therefore seems to be promising to the fight against these bacteria, but the use of this antibiotic is currently limited. In order to treat an infection caused by A. baumannii, rifabutin requires to be injected by intravenous route, which is not so easy because of the low water solubility of the molecule. Concerning the treatment of M. abscessus infections, rifabutin, although effective in vivo, has moderate activity against this mycobacterium, which could lead to therapeutic escape.Therefore, the work presented in this thesis manuscript seeks to address the limitations of rifabutin mentioned above.In a first part, water-soluble prodrugs of rifabutin have been synthesized in order to allow an intravenous injection and thus fight effectively against A. baumannii infections. To achieve the release of rifabutin after enzymatic cleavage in plasma, an intramolecular cyclization strategy was employed. After evaluation of the compounds in plasma stability assays, structure-stability relationship studies were performed, leading to the identification of three promising prodrugs. Additional in vitro studies were then conducted such as the measurement of aqueous solubility and bacterial growth inhibition, and finally an in vivo pharmacokinetic study was performed to be able to select for a preclinical candidate.In a second part, analogues of rifabutin modified at the C25 position were synthesized to identify more potent compounds. Based on a parallel chemistry strategy, a large number of derivatives were rapidly obtained and then evaluated against M. abscessus in order to conduct structure-activity relationship studies
Henein, Alexandra Elisabeth. „The potential of bacteriophage therapy in Acinetobacter spp. infections“. Thesis, University of Brighton, 2009. https://research.brighton.ac.uk/en/studentTheses/9726f331-e5dc-4b67-a282-44cac1fe978f.
Der volle Inhalt der QuelleDiallo, Bruno Salla. „Études des acinetobacter : à propos de 98 souches isolées en milieu hospitalier“. Bordeaux 2, 1990. http://www.theses.fr/1990BOR23091.
Der volle Inhalt der QuelleGagné, Stéphanie. „Étude des mécanismes de virulence du pathogène nosocomial Acinetobacter baumannii“. Thesis, Lyon, 2018. http://www.theses.fr/2018LYSE1045/document.
Der volle Inhalt der QuelleA. baumannii is an hospital acquired pathogen which causes mainly ventilator associated infection, urinary tract infection and bacteraemia. Last years Multi Drug Resistant strains increase and nosocomial infection cause by A. baumannii also which led him as a serious health care problem. We compare different strains in propose to find phenotype that can explain hypervirulent strain emergence. We studied type six secretion and showed that the complexity of A. baumannii virulence mechanism. Indeed type six secretion system regulation is strain dependant. Secondary we study hypervirulent strain and showed that intracellular stage exists and there is intracellular replication. Also hypervirulent strain induces less immune response. Those two mechanisms can explain A. baumannii hypervirulent phenotype
Fabre, David. „Approche pharmacocinétique de l'antibiothérapie dans les infections pulmonaires“. Montpellier 1, 1995. http://www.theses.fr/1995MON13504.
Der volle Inhalt der QuelleHauret, Sylvie. „Epidémiologie moléculaire d'infections nosocomiales à Acinetobacter Baumannii dans un service de réanimation“. Bordeaux 2, 1996. http://www.theses.fr/1996BOR2P039.
Der volle Inhalt der QuelleWebster, Carol Ann. „The use of molecular typing systems for studying the epidemiology of Acinetobacter infections“. Thesis, University of Nottingham, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.388315.
Der volle Inhalt der QuelleChou, So-ha, und 周素霞. „Molecular epidemiology of carbapenem-resistant acinetobacter baumanniiin patients and their surrounding environment“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48333669.
Der volle Inhalt der Quellepublished_or_final_version
Microbiology
Master
Master of Medical Sciences
Brandely, Marie-Laure. „Nouvelles prises en charge des principales infections fongiques hospitalières : évaluation pharmaco-économique“. Paris 5, 1999. http://www.theses.fr/1999PA05P183.
Der volle Inhalt der QuelleAdegoke, Anthony Ayodeji. „Commensal bacteria belonging to the Staphylococcus Acinetobacter and Stenotrophomonas genera as reservoirs of antibiotic resistance determinants in the environment of Nkonkobe Municipality, Eastern Cape Province , South Africa“. Thesis, University of Fort Hare, 2012. http://hdl.handle.net/10353/6539.
Der volle Inhalt der QuelleBücher zum Thema "Infections à Acinetobacter – Chimiothérapie"
E, Bergogne-Bérézin, Joly-Guillou M. L und Towner K. J, Hrsg. Acinetobacter: Microbiology, epidemiology, infections, management. Boca Raton: CRC Press, 1996.
Den vollen Inhalt der Quelle findenE, Bergogne-Bérézin, Friedman Herman 1931-2007 und Bendinelli Mauro, Hrsg. Acinetobacter biology and pathogenesis. New York: Springer, 2008.
Den vollen Inhalt der Quelle findenE, Bergogne-Bérézin, Friedman Herman 1931-2007 und Bendinelli Mauro, Hrsg. Acinetobacter biology and pathogenesis. New York: Springer, 2008.
Den vollen Inhalt der Quelle findenUlrike, Gerischer, Hrsg. Acinetobacter molecular biology. [Wymondham?]: Caister Academic Press, 2008.
Den vollen Inhalt der Quelle findenJacques, Thèze, und Debré Patrice, Hrsg. Le sida à l'ère des multithérapies. Paris: Elsevier, 2000.
Den vollen Inhalt der Quelle findenDariosecq, Jean-Michel. Infection VIH: Mémento thérapeutique 2003. 6. Aufl. Rueil-Malmaison: Doin, 2003.
Den vollen Inhalt der Quelle findenTaylor, Yolanda. Battling HIV/AIDS: A decision maker's guide to the procurement of medicines and related supplies. Washington, DC: World Bank, 2004.
Den vollen Inhalt der Quelle findenP, Sawan Samuel, und Manivannan Gurusamy 1960-, Hrsg. Antimicrobial/anti-infective materials: Principles, applications and devices. Lancaster, Pa: Technomic Pub. Co., 2000.
Den vollen Inhalt der Quelle findenFriedman, Herman, Mauro Bendinelli und Eugénie Bergogne-Bérézin. Acinetobacter: Biology and Pathogenesis. Springer, 2010.
Den vollen Inhalt der Quelle findenBergogne-Berezin, E., Marie-Laure Joly-Guillou und Kevin J. Towner. Acinetobacter: Microbiology, Epidemiology, Infections, Management. Taylor & Francis Group, 2020.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "Infections à Acinetobacter – Chimiothérapie"
Champion, Howard R., Nova L. Panebianco, Jan J. De Waele, Lewis J. Kaplan, Manu L. N. G. Malbrain, Annie L. Slaughter, Walter L. Biffl et al. „Acinetobacter Infections“. In Encyclopedia of Intensive Care Medicine, 41–47. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_3.
Der volle Inhalt der QuelleDijkshoorn, Lenie. „Acinetobacter baumannii“. In Molecular Typing in Bacterial Infections, 433–56. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-185-1_25.
Der volle Inhalt der QuelleNurjadi, Dennis, und Sébastien Boutin. „Acinetobacter baumannii“. In Molecular Typing in Bacterial Infections, Volume II, 113–29. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-83217-9_6.
Der volle Inhalt der QuelleJoly-Guillou, M. L. „Nosocomial and Community-acquired Acinetobacter Infections“. In Acinetobacter Biology and Pathogenesis, 155–65. New York, NY: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-77944-7_9.
Der volle Inhalt der QuelleBaneman, Emily, und Meenakshi M. Rana. „Management of Acinetobacter Infections in the Immunosuppressed Host“. In Emerging Transplant Infections, 1–19. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-01751-4_21-1.
Der volle Inhalt der QuelleBaneman, Emily, und Meenakshi M. Rana. „Management of Acinetobacter Infections in the Immunosuppressed Host“. In Emerging Transplant Infections, 371–89. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-25869-6_21.
Der volle Inhalt der QuelleRajkumari, Jobina, und Busi Siddhardha. „Acinetobacter baumannii: Infections and Drug Resistance“. In Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery, 257–71. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-1695-5_14.
Der volle Inhalt der QuelleRubinstein, E., und I. Levi. „Acinetobacter Infections in Intensive Care Units“. In Yearbook of Intensive Care and Emergency Medicine, 542–51. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-80053-5_44.
Der volle Inhalt der QuelleJoly-Guillou, M. L., E. Bergogne-Bérézin und J. F. Vieu. „Epidemiology of Acinetobacter Strains Isolated from Nosocomial Infections in France“. In The Biology of Acinetobacter, 63–68. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4899-3553-3_5.
Der volle Inhalt der QuelleVergidis, Paschalis, und Matthew E. Falagas. „Control of Multi-Drug Resistant Acinetobacter Infections“. In Antibiotic Policies, 117–25. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-1734-8_10.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Infections à Acinetobacter – Chimiothérapie"
K. Alkhudhairy, Miaad, und Elhassan Benyagoub. „Frequency of Genes Mediated β-lactams Resistance in Acinetobacter Baumannii Isolates from Iraq“. In X INTERNATIONAL CONGRESS OF PURE AND APPLIED TECHNOLOGICAL SCIENCES. Rimar Academy, 2023. http://dx.doi.org/10.47832/minarcongress10-2.
Der volle Inhalt der QuelleAl-Ghanimi, Ali Abdul Kadhim, und Amaal Sahib Al-Zughaibi. „Molecular Identification of Acinetobacter baumannii and Staphylococcus aureus isolated from wound infections in Karbala governorate Iraq“. In THE 9TH INTERNATIONAL CONFERENCE ON APPLIED SCIENCE AND TECHNOLOGY (ICAST 2021). AIP Publishing, 2022. http://dx.doi.org/10.1063/5.0113631.
Der volle Inhalt der QuelleVrancianu, Corneliu Ovidiu, Roxana-Elena Cristian, Elena-Georgiana Dobre, Catalina Zenoaga-Barbarosie, Ecaterina-Teodora Chirea, Ioana Crunteanu und Mihai-Viorel Dionisie. „The Impact of Acinetobacter baumannii Infections in COVID-19 Patients Admitted in Hospital Intensive Care Units“. In ECM 2023. Basel Switzerland: MDPI, 2023. http://dx.doi.org/10.3390/ecm2023-16479.
Der volle Inhalt der QuelleGrosse-Onnebrink, Joerg, Heymut Omran, Johanna Rudloff und Claudius Werner. „Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults“. In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa4137.
Der volle Inhalt der QuelleHodyna, Diana. „LONG-CHAIN TRIPHENYLPHOSPHONIUM IONIC LIQUIDS AS ANTIBACTERIALS IN POTENTIAL POLYMICROBIAL INFECTIONS CAUSED BY STAPHYLOCOCCUS AUREUS AND ACINETOBACTER BAUMANNII STRAINS“. In THEORETICAL AND PRACTICAL ASPECTS OF MODERN SCIENTIFIC RESEARCH, Chair Ivan Semenyuta, Sergiy Rogalsky und Larysa Metelytsia. European Scientific Platform, 2023. http://dx.doi.org/10.36074/logos-28.04.2023.26.
Der volle Inhalt der QuelleMisri, A. R. „To Study the Epidemiology of Multidrug Resistant Acinetobacter Infections Among Critically Ill Adult Patients Admitted in Medical Intensive Care Unit“. In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6508.
Der volle Inhalt der QuelleBerichte der Organisationen zum Thema "Infections à Acinetobacter – Chimiothérapie"
Meddaugh, Paul, und Uzo Chukwuma. Acinetobacter Species Infections Among Navy and Marine Corps Beneficiaries: 2013 Annual Report. Fort Belvoir, VA: Defense Technical Information Center, November 2014. http://dx.doi.org/10.21236/ada611595.
Der volle Inhalt der QuelleMeddaugh, Paul, und Uzo Chukwuma. Acinetobacter Species Infections among Navy and Marine Corps Beneficiaries: 2014 Annual Report. Fort Belvoir, VA: Defense Technical Information Center, Juli 2015. http://dx.doi.org/10.21236/ada621496.
Der volle Inhalt der QuelleMaraolo, Alberto Enrico, und David SY Ong. Colistin plus meropenem versus colistin alone for invasive infections caused by Carbapenem-Resistant Acinetobacter baumannii: a rapid systematic review of randomized controlled trials using Bayesian meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Januar 2023. http://dx.doi.org/10.37766/inplasy2023.1.0055.
Der volle Inhalt der Quelle